Neurodegenerative disease is a common and currently uncurable disorder, relating to. EFL-101 is a potent therapeutic drug as a disease-modifying therapy for patients with idiopathic or some genetic forms of the disease. The novel treatment strategy with EFL-101 is to reverse protein aggregation and inclusion body formation in selected areas of the nervous system.